NOV Analyst Ratings: 5 Experts Share Views, 12-Month Targets, and Trends

NOV (formerly National Oilwell Varco) is a leading supplier of oil and gas drilling rig equipment and products. Five analysts have shared their evaluations of NOV over the past three months, with a mix of bullish and bearish perspectives. The average 12-month price target is $17.0, with a high estimate of $22.00 and a low estimate of $10.00. Analysts have lowered their ratings and price targets in response to changes in market conditions and company performance.

NOV (formerly National Oilwell Varco), a leading supplier of oil and gas drilling rig equipment and products, has received mixed evaluations from analysts over the past three months. Five analysts have shared their perspectives, with a mix of bullish and bearish outlooks.

The average 12-month price target for NOV, based on analysts' ratings, is $17.00. This figure ranges from a high estimate of $22.00 to a low estimate of $10.00. Analysts have adjusted their ratings and price targets in response to changes in market conditions and company performance.

Analysts from Stifel Nicolaus and RBC Capital have maintained their Buy ratings, with price targets of $22.00 and $19.00, respectively. However, other analysts have shown more cautious views. Piper Sandler, TD Cowen, and Raymond James have all maintained their Hold ratings, while Wells Fargo and Goldman Sachs have issued Sell ratings. Susquehanna has lowered its price target from $19.00 to $18.00.

The analysts' ratings reflect a variety of factors, including NOV's strong financial health and attractive valuation, as well as potential risks from macroeconomic challenges and tariffs. Corporate events, such as dividends and favorable analyst ratings, have also influenced investor sentiment.

In the current month, NOV has received 14 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. The overall analyst consensus is mixed, with 14 Buy Ratings, 2 Hold Ratings, and 2 Sell Ratings. This indicates that while some analysts remain optimistic about NOV's future, others are more cautious.

References:
[1] https://www.tipranks.com/stocks/nov/forecast